GleamWall
中文EN

QTRX Quanterix Corp

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1503274 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.8%
TTM net income YoY-16.2%
TTM EPS YoY0.0%
Revenue 3-yr CAGR8.3%
Net income 3-yr CAGR—

Margins

Gross margin41.7%
Operating margin-93.2%
Net margin-75.0%
FCF margin-37.8%
EBITDA margin-76.7%

Returns

ROE-41.7%
ROA-29.9%
ROIC (approx.)-47.4%
Asset turnover0.40x

Leverage & solvency

Liabilities / assets27.0%
Debt / equity0.00x
Current ratio3.09x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.50x
Accruals ratio-14.9%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$34.97M$32.91M$36.41M$43.85M$40.23M$24.48M$30.33M$35.16M
Cost of revenue$21.47M$20.23M$20.85M$23.82M$24.33M$14.47M$15.49M$12.99M
Gross profit$13.50M$12.67M$15.57M$20.04M$15.90M$10.00M$14.84M$22.17M
R&D expense$7.37M$7.82M$7.32M$8.80M$8.01M$9.08M$10.04M$8.07M
SG&A expense$28.45M$27.35M$29.77M$35.14M$38.04M$30.35M$31.17M$28.59M
Operating income-$22.50M-$49.43M-$41.36M-$24.75M-$37.33M-$37.10M-$26.37M-$14.77M
Pretax income-$21.30M-$48.99M-$17.55M-$22.77M-$36.00M-$30.09M-$23.42M-$11.64M
Income tax$288,000-$54,000-$7,000$345,000-$2.48M-$73,000-$2.91M-$8,000
Net income-$21.59M-$48.93M-$17.54M-$23.12M-$33.52M-$30.01M-$20.50M-$11.63M
EBITDA-$16.06M-$43.30M-$35.76M-$18.52M-$31.89M-$35.10M-$24.18M-$13.05M
EPS (basic)-0.46-1.04-0.37—-0.73-0.77-0.53—
EPS (diluted)-0.46-1.04-0.37—-0.73-0.77-0.53—
Weighted avg. shares (diluted)47.39M47.17M46.98M—46.06M38.89M38.72M—
Banking
Net interest income——$892,000$1.16M$1.45M$2.69M$3.27M$3.49M
Provision for credit losses$477,000$462,000$528,000$1.00M$86,000$189,000$186,000-$32,000
Balance sheet
Cash & equivalents$35.86M$44.17M$36.18M$29.84M$38.30M$132.90M$76.51M$59.32M
Short-term investments$41.49M$49.36M$63.08M$88.39M$96.51M$128.28M$190.37M$232.41M
Receivables$27.20M$22.34M$26.78M$29.97M$33.03M$23.55M$28.26M$32.14M
Inventory$44.82M$47.60M$50.96M$54.76M$54.96M$30.14M$31.03M$32.77M
Current assets$158.12M$171.05M$185.72M$212.26M$233.28M$322.12M$335.00M$363.59M
PP&E, net$18.29M$20.00M$21.37M$23.67M$25.77M$15.75M$16.46M$17.15M
Goodwill$0$0$26.71M$26.38M$23.46M$0$6.57M$0
Intangibles$102.41M$105.78M$109.16M$131.79M$135.15M$16.33M$16.52M$4.03M
Total assets$300.44M$319.63M$366.67M$418.77M$444.14M$375.61M$396.51M$406.53M
Current liabilities$51.13M$50.37M$49.91M$74.76M$77.35M$48.20M$40.40M$42.01M
Total liabilities$81.09M$82.42M$84.53M$123.04M$129.61M$83.15M$80.12M$76.50M
Shareholders' equity$219.35M$237.21M$282.14M$295.73M$314.53M$292.46M$316.39M$330.04M
Shares outstanding47.45M47.13M47.06M46.74M46.68M38.87M38.80M38.57M
Cash flow statement
Operating cash flow-$16.20M-$5.12M-$18.11M-$16.44M-$41.25M-$5.66M-$13.89M-$4.30M
Capital expenditure$75,000$96,000$87,000-$98,000$677,000$777,000$1.26M$412,000
Free cash flow-$16.28M-$5.21M-$18.19M-$16.35M-$41.93M-$6.43M-$15.14M-$4.71M
Investing cash flow$7.90M$13.66M$25.26M$8.44M-$52.85M$61.88M$32.76M$32.38M
Financing cash flow$52,000-$527,000-$770,000-$522,000$150,000-$429,000$93,000$41,000
Depreciation & amortization$6.43M$6.13M$5.60M$6.23M$5.43M$2.00M$2.19M$1.72M
Stock-based compensation$3.78M$4.21M$4.53M$4.42M$5.47M$5.37M$5.46M$4.84M

Free plan shows the latest 8 periods; Pro shows all 39 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.